Figure 1

![Figure 1: Literature review summary of novel anti-inflammatory treatment candidates for liver cirrhosis, organized by mechanism of action including cytokine modulation, gut-liver axis targeting, and immune cell regulation. The evidence base ranges from preclinical to early clinical studies.]()

> Source: Thit Mynster Kronborg et al. "Novel Anti-inflammatory Treatments in Cirrhosis. A Literature-Based Study.." *Frontiers in medicine*, 2021. PMID: [34631742](https://pubmed.ncbi.nlm.nih.gov/34631742/)

<figure>
  <img src="" alt="Literature review summary of novel anti-inflammatory treatment candidates for liver cirrhosis, organized by mechanism of action including cytokine modulation, gut-liver axis targeting, and immune cell regulation. The evidence base ranges from preclinical to early clinical studies." />
  <figcaption>Figure 1. Literature review summary of novel anti-inflammatory treatment candidates for liver cirrhosis, organized by mechanism of action including cytokine modulation, gut-liver axis targeting, and immune cell regulation. The evidence base ranges from preclinical to early clinical studies.<br>  Source: Thit Mynster Kronborg et al. "Novel Anti-inflammatory Treatments in Cirrhosis. A Literature-Based Study.." <em>Frontiers in medicine</em>, 2021. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/34631742/">34631742</a></figcaption>
</figure>